Kumada Hiromitsu | Department Of Gastroenterology Toranomon Hospital
スポンサーリンク
概要
関連著者
-
Kumada Hiromitsu
Department Of Gastroenterology Toranomon Hospital
-
KUMADA Hiromitsu
Department of Hepatology, Toranomon Hospital
-
IKEDA Kenji
Department of Hepatology, Toranomon Hospital
-
SUZUKI Yoshiyuki
Department of Radiation Oncology, Gunma University Graduate school of Medicine
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓科
-
Saitoh Satoshi
Department of Cardiology, Nihon University School of Medicine
-
Saitoh Satoshi
Department Of Hepatology Toranomon Hospital
-
Saitoh S
Department Of Hepatology Toranomon Hospital
-
Saitoh Satoshi
国家公務員共済組合連合会虎の門病院 肝臓内科
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓内科
-
Kumada Hiromitsu
冲中記念成人病研究所
-
KUMADA Hiromitsu
Toranomon Hospital
-
Sezaki Hitomi
Department Of Hepatology Toranomon Hospital
-
HOSAKA Tetsuya
Department of Hepatology, Toranomon Hospital
-
Chayama Kazuaki
Department of Medicine and Molecular Biology, Hiroshima University School of Medicine
-
Kumada Hiromitsu
Department Of Hepatology Toranomon Hospital
-
KAWAMURA Yusuke
Department of Hepatology, Toranomon Hospital
-
Ohno Tomoyoshi
Department Of Gastroenterology Social Insurance Chukyo Hospital
-
Ohno Tomoyoshi
社会保険中京病院 消化器科
-
OHNO Tomoyoshi
Nagoya City University School of Medicine
-
Okanoue Takeshi
愛生会山科病院 内科
-
HIRAKAWA Miharu
Department of Hepatology, Toranomon Hospital
-
Yoshida H
National Hospital Organization Nagasaki Medical Center
-
KOBAYASHI Mariko
Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
IZUMI Namiki
Musashino Red Cross Hospital
-
MORIWAKI H.
Gifu University School of Medicine
-
Moriwaki H
First Department Of Internal Medicine Gifu University Graduate School Of Medicine
-
Moriwaki Hisataka
岐阜大学 医学部内科学
-
YOSHIHARA Harumasa
Osaka Rousai Hospital
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University
-
Takehara Tetsuo
京都府立医科大学 消化器内科学
-
Yoshioka K
Nagoya Univ. School Of Medicine
-
Yoshioka Kentaro
名古屋大学 医学部第3内科学
-
Yoshioka Kentaro
Department Of Hepato-biliary-pancreas Fujita Health Science
-
Okanoue T
Division Of Gastroenterology Saiseikai Suita Hospital
-
Yamanouchi Kunio
稲沢市民病院
-
TANAKA Eiji
Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate Sch
-
TANAKA Eiji
Shinsyu University Graduate School of Medicine
-
IZUMI Namiki
Department of Gastroenterology and Hepatology, Musashino Red-Cross Hospital
-
Taniguchi E
Department Of Medicine Kurume University School Of Medicine
-
Taniguchi Eitaro
Second Department Of Medicine Kurume University School Of Medicine
-
YOTSUYANAGI Hiroshi
Department of Infections Diseases, Internal Medicine, University of Tokyo
-
MIYAKAWA Yuzo
Miyakawa Memorial Research Foundation
-
ONJI Morikazu
Department of Gastroenterology and Metabology, Ehime University
-
Nomura Hideyuki
The Center For Liver Diseases Shin-kokura Hospital
-
Moriwaki Hisataka
Dep. Of Gastroenterology Gifu Univ. School Of Medicine
-
Moriwaki Hisataka
東京大学医科学研究所
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Takehara Tetsuo
大阪大学 医学系研究科消化器内科
-
YOSHIOKA KENTARO
Division of Gastroenterology, Department of Internal Medicine, Nagoya University School of Medicine
-
Sakata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
京都府立医科大学 消化器内科学
-
NISHIGUCHI Shuhei
Department of Internal Medicine, Hyogo College of Medicine
-
IINO Shiro
Kiyokawa Hospital
-
HINO Keisuke
Yamaguchi University School of Medicine
-
Iida S
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Itoh Yoshito
愛生会山科病院 内科
-
Yoshioka Kentaro
Division Of Liver Biliary Tract And Pancreas Diseases Department Of Internal Medicine Fujita Health
-
Sata Michio
久留米大学 医学部免疫学講座
-
Murakami Masato
Department Of Radiology Ehime Prefectural Central Hospital
-
MORIWAKI Hisataka
Department of Internal Medicine, Gifu University Graduate School of Medicine
-
UENO Yoshiyuki
Division of Gastroenterology, Tohoku University Graduate School of Medicine
-
Saito satoshi
Department of Medicine, Division of Cardiovascular Medicine, Nihon University School of Medicine
-
SAKISAKA Shotaro
Department of Gastroenterology and Medicine, Fukuoka University School of Medicine
-
WATANABE Sumio
Department of Gastroenterology, Juntendo University School of Medicine
-
HASHIMOTO MICHIE
Department of Medical Sciences, Toshiba General Hospital
-
Sata Michio
久留米大学 大学院医学研究科消化器疾患情報講座
-
Sata Michio
大腸肛門病センターくるめ病院
-
SATA Michio
Second Department of Internal Medicine, Kurume University
-
AKAHANE Yoshihiro
University of Yamanashi
-
OKANOUE Takeshi
Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto P
-
Okita K
Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine
-
Okita Kiwamu
山口大学 医学部消化器病態内科
-
Okita Kiwamu
山口大学 医学部
-
Okita Kiwamu
京都府立医科大学 消化器内科学
-
Hisai H
Department Of Medicine Aichi Gakuin University School Of Pharmacy
-
Hashimoto Hiroaki
済生会吹田病院
-
Iwahashi Hiromi
Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine
-
Moriwaki Hisataka
がん･感染症センター都立駒込病院 肝臓内科
-
OSHITA Masahide
Osaka Police Hospital
-
Haruna Yoshimichi
大阪大学 医学系研究科消化器内科学
-
Hiramatsu Naoki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hiramatsu Naoki
大阪大学 医学系研究科消化器内科
-
Inoue Yuko
大阪大学 医学系研究科消化器内科
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Oshita Masahide
Department Of Internal Medicine Osaka Police Hospital
-
Oshita Masahide
大阪大学 医学系研究科消化器内科
-
Inui Yoshiaki
大阪大学 医学系研究科消化器内科
-
Iida Shinsuke
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
SUZUKI Hiroshi
Yamanashi University
-
IINO SHIRO
Department of Medicine, Seizankai Kiyokawa Hospital
-
Ogata Kei
久留米大学 医学部第2内科消化器内科部門
-
Ogata Kei
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Hayashi Hisao
愛知学院大学 薬学部薬物治療学
-
Sata M
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Sata Michio
久留米大学先端癌治療研究センター
-
Sata Michio
久留米大学 消化器内科
-
Nakamura Yusuke
Center for Genomic Medicine, RIKEN
-
HASHIMOTO Hiroaki
Department of Bioresource Science and Technology, Graduate School of Biosphere Science, Hiroshima Un
-
MAEKAWA Toshiro
Laboratory of Genetical Biochemistry and Signal Biology, Graduate School of Medical Sciences, Kitasa
-
SUZUKI Hajime
National Insitute for Fusion Science
-
Kimura Takashi
Department of Neurology, National Douhoku Hospital
-
Kaneko Shuichi
Department Of Disease Control And Homeostasis Kanazawa University Graduate School Of Medical Science
-
Kakumu S
Division Of Gastroenterology Department Of Internal Medicine Aichi Medical University School Of Medi
-
KUDO Masatoshi
Department of Gastroenterology, Kinki University Medical School of Medicine
-
Imai Yasuharu
Departments Of Pediatric Cardiovascular Surgery The Heart Institute Of Japan Tokyo Women's Medi
-
Imai Yasuharu
Department Of Gastroenterology Ikeda Municipal Hospital
-
有川 二郎
北海道大学医学部附属動物実験施設
-
Ohashi Yasuo
Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences a
-
Kihara Shinji
Department Of Metabolic Medicine Osaka University Graduate School Of Medicine
-
TSUJI Hiroshi
Department of Electronic Science and Engineering, Kyoto University
-
鈴木 博
理化学研究所仁科加速器研究センター川合理論物理学研究室
-
YANO Michitami
Institute for Clinical Research
-
ITOH Yoshito
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School
-
MINAMI Masahito
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School
-
IDE Tatsuya
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine
-
Ide Tatsuya
久留米大学 医学部免疫学講座
-
Ide T
Department Of Second Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Second Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
久留米大学 医学部内科学第二
-
Tsubouchi Hirohito
Department Of Digestive And Life-style Related Disease Kagoshima University Graduate School Of Medic
-
Tsubouchi Hirohito
大阪大学 医学系研究科消化器内科学
-
Tsubouchi H
Department Of Internal Medicine Ii Miyazaki University School Of Medicine
-
KOIKE Kazuhiko
Department of Marine Biochemistry, School of Marine Sciences, Kitasato University
-
KUMADA Takashi
Department of Gastroenterology, Ogaki Municipal Hospital
-
Sata Michio
久留米大学 医学部消化器外科
-
Shimoda Tadakazu
国立がんセンター中央病院
-
Shimoda Tadakazu
獨協医科大学 病理学人体分子
-
Moriyasu Fuminori
Department Of Gastroenterology And Hepatology Tokyo Medical University
-
YAMADA Gotaro
Kawasaki Hospital
-
MIZOKAMI Masashi
Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Med
-
OKANOUE Takeshi
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
-
HASHIMOTO Hiroaki
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
-
YASUI Kohichiro
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University
-
YAMADA Gotaro
Department of Gastroenterology and Metabology, Kawasaki Hospital
-
OKITA Kiwamu
Center of Liver Disease, Social Insurance Alliance Shimonoseki Hospital
-
ICHIDA Takafumi
Department of Gastroenterology, Juntendo University School of Medicine, Shizuoka Hospital
-
OGATA Kei
Second Department of Internal Medicine, Kurume University
-
KUMASHIRO Ryukichi
Second Department of Internal Medicine, Kurume University
-
OKITA Kiwamu
Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
-
AKAHANE Yoshihiro
First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi
-
TSUBOUCHI Hirohito
Second Department of Internal Medicine, Faculty of Medicine, The University of Miyazaki
-
MORIWAKI Hisataka
First Department of Internal Medicine, Gifu University School of Medicine
-
KAKUMU Shinichi
Department of Internal Medicine, GI Division, Aichi Medical University School of Medicine
-
IINO Shiro
Seizankai Kiyokawa Hospital
-
OZEKI Itaru
Department of Internal Medicine (Section 1), Teine Luke Hospital
-
Tomita Eiichi
Department Of Gastroenterology Gifu Municipal Hospital
-
Imawari Michio
Department Of Gastroenterology Showa University School Of Medicine
-
Hige Shuhei
Department Of Gastroenterology And Hematology Hokkaido University
-
HAYASHI Norio
Department of Biochemistry, Tohoku University School of Medicine
-
Okita Kiwamu
下関厚生病院(社保)
-
TODA Gotaro
Department of Internal Medicine, The Jikei University School of Medicine
-
Mori Nami
Department of Cardiology, Fujita Health University School of Medicine
-
Sato Shunichi
First Department Of Internal Medicine Iwate Medical University School Of Medicine
-
Sato Shinichiro
岩手医科大学 医学部内科学第一
-
Kumashiro Ryukichi
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Kuwahara Seiichiro
久留米大学 医学部第2内科消化器内科部門
-
Ishii Hiromasa
Department of Public Health, Tokai University School of Medicine
-
SUZUKI KAZUYUKI
First Department of Internal Medicine, Iwate Medical University
-
NISHIGUCHI Shuhei
Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of
-
Matsuo Keitaro
愛知県がんセンター研究所 疫学･予防部
-
Sainokami Shigehiko
岩手医科大学 医学部内科学第一
-
Sainokami Shigehiko
The First Department Of Internal Medicine Iwate Medical University
-
Suzuki Kazuyuki
Division Of Gastroenterology And Hepatology Department Of Internal Medicine Iwate Medical University
-
Suzuki Kazuyuki
岩手医科大学 医学部内科学講座消化器･肝臓内科
-
Sato Shunichi
First Department Of Internal Medicine Iwate Medical University
-
Ide Tatsuya
久留米大学 医学部消化器内科
-
Ide Tatsuya
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
The Second Department Of Medicine Kurume University School Of Medicine
-
Ide Tatsuya
2nd Department Of Internal Medicine Kurume University School Of Medicine
-
Ide Tatsuya
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Kato Akinobu
First Department of Internal Medicine, Iwate Medical University
-
Ishii Hiromasa
神戸大学 医学部内科学
-
Kawata Sumio
Department Of Gastroenterology Faculty Of Medicine Yamagata University
-
Kawata S
Second Department Of Internal Medicine Yamagata University School Of Medicine
-
Hayashi Noriyuki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kihara Shinji
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kihara Shinji
大阪大学 医学系研究科消化器内科学
-
HIRAMATSU Naoki
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
KUBOTA SHINJI
Kansai Rousai Hospital
-
Hayashi Eijirou
大阪大学
-
Hayashi Norio
大阪大学 医学系研究科消化器内科
-
Inui Y
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Imai Yasuharu
大阪大学 医学系研究科消化器内科
-
Kiso Shinichi
Second Department Of Internal Medicine Osaka University Medical School
-
Kubota Shinji
大阪大学 医学系研究科消化器内科学
-
Ohkawa Kazuyoshi
大阪大学
-
Inui Yoshiaki
Second Department Of Internal Medicine Osaka University Medical School
-
HINO KEISUKE
Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
-
ITOH YOSHITO
Department of Molecular Therapeutics, Osaka University Graduate School of Medicine
-
Iida Shinsuke
名古屋市立大学 医学研究科腫瘍免疫内科学
-
KIYOSAWA Kendo
Shinshu University School of Medicine
-
MATSUSHIMA Takashi
Municipal Hakodate Hospital
-
Sata Michio
久留米大学 医学部消化器内科部門
-
Miki Daiki
Department Of Medicine And Molecular Science Programs For Biomedical Research Graduate School Of Bio
-
Kondo Fukuo
Department Of Pathology Chiba University School Of Medicine
-
Kariwa Hiroaki
Hokkaido Univ. Sapporo Jpn
-
Kariwa Hiroaki
Laboratory Of Public Health Department Of Environmental Veterinary Sciences Graduate School Of Veter
-
HASHIMOTO Etsuko
Department of Medicine and Gastroenterology, Tokyo Women's Medical University
著作論文
- Efficacy and Safety of Combination Therapy of Natural Human Interferon β and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load
- Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
- Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
- The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
- Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
- Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
- Involvement of GBV-C/HGV in liver diseases in Japan
- Clinical features of hepatitis B virus genotype A in Japanese patients
- Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
- Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
- Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
- Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
- Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
- Efficacy of interferon therapy for aged patients with chronic hepatitis C
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
- Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
- Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
- A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
- Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load
- Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection
- Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patients
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
- The Development of Chronic Kidney Disease in Japanese Patients with Non-alcoholic Fatty Liver Disease
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
- Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection
- Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
- Interferon and lamivudine monotherapy on chronic hepatitis B in Japan
- Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
- New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
- Psychiatric symptoms related to interferon therapy for chronic hepatitis C : Clinical features and prognosis
- Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C patients
- Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation : A retrospective study of hepatitis C virus-related liver cancer
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
- Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C Patients with Genotype 1b and Low-virus Load
- The Efficacy of Short-term Interferon-beta Therapy for Chronic Hepatitis C Patients with Low Virus Load
- Natural Human Interferon β Plus Ribavirin Combination Therapy in Japanese Patients Infected with Hepatitis C Virus and a High Viral Load
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
- Prolonged Hepatitis after Acute Infection with Genotype H Hepatitis B Virus
- Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan
- Suitable Treatment Period in Patients with Virological Response during Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C
- Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection
- Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C
- Serum KL-6 Level is Elevated in Chronic Hepatitis C Patients with Combination Therapy of Pegylated Interferon and Ribavirin
- Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderlv patients
- Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy
- Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus
- Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus load
- Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of
- Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively
- Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis
- Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B : results from a nine-year longitudinal study
- Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers
- Magnetic resonance laparoscopy : A new non-invasive technique for the assessment of chronic viral liver disease
- Fibrosis score consisting of serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B